I-BET151 (GSK1210151A)
99%
- Product Code: 100887
CAS:
1300031-49-5
| Molecular Weight: | 415.44 g./mol | Molecular Formula: | C₂₃H₂₁N₅O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22124472 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
I-BET151 (GSK1210151A) is primarily used in research and development for its role as a BET bromodomain inhibitor. It is studied for its potential therapeutic applications in cancer treatment, as it can disrupt the function of proteins involved in regulating gene expression, particularly in cancer cells. This compound is also explored in the context of inflammatory diseases, as it may modulate immune responses by targeting specific pathways. Additionally, I-BET151 is utilized in preclinical studies to better understand epigenetic mechanisms and their influence on disease progression. Its application in drug discovery aims to develop targeted therapies for conditions driven by abnormal gene expression.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Off-White Solid |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿5,390.00 |
+
-
|
| 0.005 | 10-20 days | ฿13,470.00 |
+
-
|
| 0.010 | 10-20 days | ฿22,940.00 |
+
-
|
I-BET151 (GSK1210151A)
I-BET151 (GSK1210151A) is primarily used in research and development for its role as a BET bromodomain inhibitor. It is studied for its potential therapeutic applications in cancer treatment, as it can disrupt the function of proteins involved in regulating gene expression, particularly in cancer cells. This compound is also explored in the context of inflammatory diseases, as it may modulate immune responses by targeting specific pathways. Additionally, I-BET151 is utilized in preclinical studies to better understand epigenetic mechanisms and their influence on disease progression. Its application in drug discovery aims to develop targeted therapies for conditions driven by abnormal gene expression.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :